Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
about
Database Research for Pediatric Infectious DiseasesUsing Length of Stay to Control for Unobserved Heterogeneity When Estimating Treatment Effect on Hospital Costs with Observational Data: Issues of Reliability, Robustness, and UsefulnessHospital outcomes associated with guideline-recommended antibiotic therapy for pediatric pneumonia.The Impact of Adherence to Pediatric Community-Acquired Pneumonia Guidelines on Clinical OutcomesUncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence.The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.Recent Developments in Pediatric Community-Acquired Pneumonia.Impact of a National Guideline on Antibiotic Selection for Hospitalized Pneumonia.Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.La pneumonie non compliquée chez les enfants et les adolescents canadiens en santé : points de pratique sur la prise en charge.Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis.Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.Treatment of Community-Acquired Pneumonia: Are All Countries Treating Children in the Same Way? A Literature Review.Advances in Pediatric Pharmacology, Therapeutics, and Toxicology.
P2860
Q26781065-2198BA52-E9E7-4120-937D-54C3AAD86F0AQ31048039-4ABAABF4-C3F6-4DDD-A70B-7AB2FCB80945Q35067516-7CBF2EB7-DA14-4807-A8BB-D3C54C1F0A1BQ35638986-E66CF9EC-41AB-4FA4-A3DA-A8B5BEDF39E5Q36425466-48347550-C0B3-4645-A45C-8D9E1A796B7CQ38344368-EB46D55A-9840-47AE-A19D-9032290A4589Q38628311-EF092333-AF6E-430C-A35F-A1757A8DAB7BQ38682463-C62D3349-4F62-4C45-A596-4A6CBA66D97BQ38767450-E3D00F1A-9C2B-4ED2-A634-7F6E90D6BC84Q38919609-A440852B-D485-49B3-B5CB-D8D77C5DD97DQ38922276-9E5A8CA8-66C4-42BF-8814-E6B63E089164Q46486735-D076ABCE-66D5-4DED-9393-EB16B9B99D65Q47139802-F86D1B4B-5D06-40FA-B228-4DC0960D17BDQ47547063-BE897AFA-5147-4706-BE5B-042DBA0179FEQ48130054-F135DB84-EC0E-47BD-B154-CA5F9D749C0AQ54194778-44853282-40D4-43F1-ADB6-5BEB87CBBFE3
P2860
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@ast
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@en
type
label
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@ast
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@en
prefLabel
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@ast
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@en
P2093
P2860
P356
P1433
P1476
Comparative effectiveness of empiric antibiotics for community-acquired pneumonia
@en
P2093
Angela L Myers
Angela M Statile
Derek J Williams
Joel S Tieder
Karen E Jerardi
Katherine A Auger
Mary Ann Queen
Matthew Hall
P2860
P356
10.1542/PEDS.2013-1773
P407
P577
2013-12-09T00:00:00Z